Cargando…

Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis

Ferredoxin 1 (FDX1) functions by transferring electrons from NADPH to mitochondrial cytochrome P450 via the ferredoxin reductase and is the key regulator in copper-dependent cell death. Although mounting evidence supports a vital role for FDX1 in tumorigenesis of some cancers, no pan-cancer analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Longfei, Zhang, Yuwei, Wang, Yang, Jiang, Peng, Liu, Fengping, Feng, Ninghan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532935/ https://www.ncbi.nlm.nih.gov/pubmed/36210836 http://dx.doi.org/10.3389/fphar.2022.938134

Ejemplares similares

A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance
por: Yang, Longfei, et al.
Publicado: (2023)

Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1
por: Quan, Yingyao, et al.
Publicado: (2023)

Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer
por: Li, Xiang, et al.
Publicado: (2022)

Role of PRDM1 in Tumor Immunity and Drug Response: A Pan-Cancer Analysis
por: Shen, Lujun, et al.
Publicado: (2020)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
por: Li, Mingzhe, et al.
Publicado: (2022)

Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies
por: Bian, Chenbin, et al.
Publicado: (2023)

Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma
por: Lv, Haozhen, et al.
Publicado: (2022)

Prognostic and immune correlation evaluation of a novel cuproptosis-related genes signature in hepatocellular carcinoma
por: Zhou, Zheng, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer
por: Wang, Qiang, et al.
Publicado: (2022)

Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy
por: Yang, Xiaolin, et al.
Publicado: (2023)

Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases
por: Yang, Yang, et al.
Publicado: (2023)

Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
por: Wu, Xiwen, et al.
Publicado: (2023)

Prognostic value of cuproptosis-related genes signature and its impact on the reshaped immune microenvironment of glioma
por: Chen, Siliang, et al.
Publicado: (2022)

Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer
por: Li, Jixian, et al.
Publicado: (2023)

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma
por: Sun, Yuming, et al.
Publicado: (2023)

An effective prognostic model in colon adenocarcinoma composed of cuproptosis-related epigenetic regulators
por: Liu, Yang, et al.
Publicado: (2023)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2023)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
por: Xie, Tongjin, et al.
Publicado: (2022)

C1QTNF6 is a Prognostic Biomarker and Related to Immune Infiltration and Drug Sensitivity: A Pan-Cancer Analysis
por: Liu, Wei, et al.
Publicado: (2022)

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response
por: Ma, Yun-Long, et al.
Publicado: (2023)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
por: Ma, Chao, et al.
Publicado: (2023)

Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance
por: Pan, Shize, et al.
Publicado: (2022)

Comprehensive analysis of the cuproptosis-related gene DLD across cancers: A potential prognostic and immunotherapeutic target
por: Yang, Weiguang, et al.
Publicado: (2023)

Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis
por: Qin, Yan, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma
por: Zhang, Mengzhe, et al.
Publicado: (2023)

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy
por: Song, Shuailing, et al.
Publicado: (2023)

Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer
por: Zhou, Cankun, et al.
Publicado: (2022)

Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma
por: Qi, Xiangjun, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
por: Xu, Qi-Tong, et al.
Publicado: (2023)

Prognostic and immunological role of cuproptosis-related protein FDX1 in pan-cancer
por: Xiao, Chen, et al.
Publicado: (2022)

Integrative Pan-Cancer Analysis Confirmed that FCGR3A is a Candidate Biomarker Associated With Tumor Immunity
por: Li, Lilin, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related genes signature associated with prognosis, clinical implications and immunotherapy of hepatocellular carcinoma
por: He, Fengjiao, et al.
Publicado: (2023)

Cuproptosis signature and PLCD3 predicts immune infiltration and drug responses in osteosarcoma
por: Hu, Hai, et al.
Publicado: (2023)

Cuproptosis patterns and tumor immune infiltration characterization in colorectal cancer
por: Du, Yan, et al.
Publicado: (2022)

Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis
por: Liu, Xu-Sheng, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma
por: Li, Yaoting, et al.
Publicado: (2023)

A tumor-associated endothelial signature score model in immunotherapy and prognosis across pan-cancers
por: Chen, Shuzhao, et al.
Publicado: (2023)

NADP(H) allosterically regulates the interaction between ferredoxin and ferredoxin‐NADP(+) reductase
por: Kimata‐Ariga, Yoko, et al.
Publicado: (2019)

Pan-Cancer Analysis and Drug Formulation for GPR139 and GPR142
por: Kaushik, Aman Chandra, et al.
Publicado: (2021)

Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma
por: Lu, Hanwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gpg3b3llu8hrvc7snkn722l1c1